Why the study?
Delays in ATTR-CM diagnosis cause significant morbidity, and while screening algorithms may improve timely diagnosis, their performance and potential bias have not been directly compared.
Do deep learning echocardiography models improve the detection of ATTR-CM compared to claims-based or regression-based scores in patients with heart failure?
Do deep learning echocardiography models improve the detection of ATTR-CM compared to claims-based or regression-based scores in patients with heart failure?
Deep learning echocardiography-based models demonstrated superior discrimination for detecting ATTR-CM compared to claims-based or regression-based scores, with a low risk of racial bias.
Answers are grounded in this paper and cite their sources.
May improve ATTR-CM detection in HF; extends prior scores but leaves open prospective validation before practice change.
BACKGROUND: Delays in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) contribute to the significant morbidity of the condition, especially in the era of disease-modifying therapies. Screening for ATTR-CM with artificial intelligence and other algorithms may improve timely diagnosis, but these algorithms have not been directly compared. OBJECTIVES: The aim of this study was to compare the performance of 4 algorithms for ATTR-CM detection in a heart failure population and assess the risk for harms due to model bias. METHODS: We identified patients in an integrated health system from 2010 to 2022 with ATTR-CM and age- and sex-matched them to controls with heart failure to target 5% prevalence. We compared the performance of a claims-based random forest model (Huda et al model), a regression-based score (Mayo ATTR-CM), and 2 deep learning echo models (EchoNet-LVH and EchoGo Amyloidosis). We evaluated for bias using standard fairness metrics. RESULTS: The analytical cohort included 176 confirmed cases of ATTR-CM and 3,192 control patients with 79.2% self-identified as White and 9.0% as Black. The Huda et al model performed poorly (AUC: 0.49). Both deep learning echo models had a higher AUC when compared to the Mayo ATTR-CM Score (EchoNet-LVH 0.88; EchoGo Amyloidosis 0.92; Mayo ATTR-CM Score 0.79; DeLong P < 0.001 for both). Bias auditing met fairness criteria for equal opportunity among patients who identified as Black. CONCLUSIONS: Deep learning, echo-based models to detect ATTR-CM demonstrated best overall discrimination when compared to 2 other models in external validation with low risk of harms due to racial bias.
No takes yet. Share an insight, caveat, or question.
Hourmozdi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: